Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Oct;116(4):2322–2326. doi: 10.1111/j.1476-5381.1995.tb15072.x

Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.

R P Waite 1, S L Lim 1, C C Pang 1
PMCID: PMC1908986  PMID: 8564267

Abstract

1. The effects of the potassium channel opener, pinacidil, on mean arterial pressure (MAP), mean circulatory filling pressure (MCFP), total peripheral resistance (TPR), cardiac output (CO) and resistance to venous return (Rv) were studied in rats. 2. In pentobarbitone-anaesthetized rats given mecamylamine (ganglionic blocker, 3.7 micrograms kg-1) and noradrenaline (1.5 micrograms kg-1 min-1) to suppress autonomic reflexes, pinacidil (60 and 180 micrograms kg-1 min-1), relative to the vehicle, reduced MAP and TPR in a dose-dependent manner but did not significantly alter CO, MCFP or RV. 3. Pinacidil (10-300 micrograms kg-1 min-1) caused similar increases in MCFP, an inverse index of venous compliance, and similar dose-dependent reductions in mean arterial pressure (MAP) in conscious, intact rats and rats infused with the ganglionic blocker, hexamethonium (150 micrograms kg-1 min-1). In rats with vasomotor tone elevated by the infusion of noradrenaline (1.5 micrograms kg-1 min-1), pinacidil caused markedly greater depressor responses but did not significantly alter MCFP. 4. Our results show that pinacidil is an efficacious vasodilator of arterial resistance blood vessels but has little venodilator activity.

Full text

PDF
2322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdelrahman A., Pang C. C. Calcitonin gene-related peptide is a venous dilator in conscious rats. Eur J Pharmacol. 1992 Jul 7;217(2-3):185–189. doi: 10.1016/0014-2999(92)90845-u. [DOI] [PubMed] [Google Scholar]
  2. Abdelrahman A., Pang C. C. Differential venous effects of isoprenaline in conscious rats. Eur J Pharmacol. 1990 Nov 13;190(3):321–327. doi: 10.1016/0014-2999(90)94196-5. [DOI] [PubMed] [Google Scholar]
  3. Cai B., Hao Q., Greenberg S. S., deBoisblanc B., Gillott D., Goharderakhshan R., Summer W. R., Hyman A., Lippton H. Differential effects of pinacidil and cromakalim on vascular relaxation and sympathetic neurotransmission. Can J Physiol Pharmacol. 1994 Jul;72(7):801–810. doi: 10.1139/y94-114. [DOI] [PubMed] [Google Scholar]
  4. Cook N. S., Quast U., Hof R. P., Baumlin Y., Pally C. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol. 1988 Jan;11(1):90–99. doi: 10.1097/00005344-198801000-00014. [DOI] [PubMed] [Google Scholar]
  5. D'Oyley H. M., Pang C. C. Effects of alpha 1- and alpha 2-adrenoceptor antagonists on venous tone in conscious rats. Eur J Pharmacol. 1990 Jul 3;182(2):283–290. doi: 10.1016/0014-2999(90)90287-g. [DOI] [PubMed] [Google Scholar]
  6. D'Oyley H. M., Tabrizchi R., Pang C. C. Effects of vasodilator drugs on venous tone in conscious rats. Eur J Pharmacol. 1989 Mar 21;162(2):337–344. doi: 10.1016/0014-2999(89)90297-5. [DOI] [PubMed] [Google Scholar]
  7. Edwards G., Henshaw M., Miller M., Weston A. H. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro. Br J Pharmacol. 1991 Mar;102(3):679–686. doi: 10.1111/j.1476-5381.1991.tb12233.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edwards G., Weston A. H. KATP--fact or artefact? New thoughts on the mode of action of the potassium channel openers. Cardiovasc Res. 1994 Jun;28(6):735–745. doi: 10.1093/cvr/28.6.735. [DOI] [PubMed] [Google Scholar]
  9. Hermsmeyer K. Ion channel effects of pinacidil in vascular muscle. Drugs. 1988;36 (Suppl 7):29–32. doi: 10.2165/00003495-198800367-00005. [DOI] [PubMed] [Google Scholar]
  10. Longman S. D., Clapham J. C., Wilson C., Hamilton T. C. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil. J Cardiovasc Pharmacol. 1988;12(5):535–542. [PubMed] [Google Scholar]
  11. Pang C. C. Effect of vasopressin antagonist and saralasin on regional blood flow following hemorrhage. Am J Physiol. 1983 Nov;245(5 Pt 1):H749–H755. doi: 10.1152/ajpheart.1983.245.5.H749. [DOI] [PubMed] [Google Scholar]
  12. Pang C. C., Tabrizchi R. The effects of noradrenaline, B-HT 920, methoxamine, angiotensin II and vasopressin on mean circulatory filling pressure in conscious rats. Br J Pharmacol. 1986 Oct;89(2):389–394. doi: 10.1111/j.1476-5381.1986.tb10272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Quast U. Do the K+ channel openers relax smooth muscle by opening K+ channels? Trends Pharmacol Sci. 1993 Sep;14(9):332–337. doi: 10.1016/0165-6147(93)90006-6. [DOI] [PubMed] [Google Scholar]
  14. Quast U. Potassium channel openers: pharmacological and clinical aspects. Fundam Clin Pharmacol. 1992;6(7):279–293. doi: 10.1111/j.1472-8206.1992.tb00122.x. [DOI] [PubMed] [Google Scholar]
  15. Rothe C. F. Mean circulatory filling pressure: its meaning and measurement. J Appl Physiol (1985) 1993 Feb;74(2):499–509. doi: 10.1152/jappl.1993.74.2.499. [DOI] [PubMed] [Google Scholar]
  16. Southerton J. S., Weston A. H., Bray K. M., Newgreen D. T., Taylor S. G. The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):310–318. doi: 10.1007/BF00173406. [DOI] [PubMed] [Google Scholar]
  17. Steinberg M. I., Ertel P., Smallwood J. K., Wyss V., Zimmerman K. The relation between vascular relaxant and cardiac electrophysiological effects of pinacidil. J Cardiovasc Pharmacol. 1988;12 (Suppl 2):S30–S40. doi: 10.1097/00005344-198812002-00007. [DOI] [PubMed] [Google Scholar]
  18. Tabrizchi R., Lim S. L., Pang C. C. Possible equilibration of portal venous and central venous pressures during circulatory arrest. Am J Physiol. 1993 Jan;264(1 Pt 2):H259–H261. doi: 10.1152/ajpheart.1993.264.1.H259. [DOI] [PubMed] [Google Scholar]
  19. Tabrizchi R., Pang C. C. Effects of drugs on body venous tone, as reflected by mean circulatory filling pressure. Cardiovasc Res. 1992 May;26(5):443–448. doi: 10.1093/cvr/26.5.443. [DOI] [PubMed] [Google Scholar]
  20. Toda N., Nakajima S., Miyazaki M., Ueda M. Vasodilatation induced by pinacidil in dogs. Comparison with hydralazine and nifedipine. J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1118–1126. doi: 10.1097/00005344-198511000-00017. [DOI] [PubMed] [Google Scholar]
  21. Waite R. P., Pang C. C., Walker M. J. Effects of calcium antagonists on mean circulatory filling pressure in the conscious rat. J Cardiovasc Pharmacol. 1988;12(5):499–504. doi: 10.1097/00005344-198811000-00001. [DOI] [PubMed] [Google Scholar]
  22. Wang Y. X., Lim S. L., Pang C. C. Increase by NG-nitro-L-arginine methyl ester (L-NAME) of resistance to venous return in rats. Br J Pharmacol. 1995 Apr;114(7):1454–1458. doi: 10.1111/j.1476-5381.1995.tb13369.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Weston A. H., Bray K. M., Duty S., McHarg A. D., Newgreen D. T., Southerton J. S. In vitro studies on the mode of action of pinacidil. Drugs. 1988;36 (Suppl 7):10–28. doi: 10.2165/00003495-198800367-00004. [DOI] [PubMed] [Google Scholar]
  24. Zografos P., Li J. H., Kau S. T. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs. Pharmacology. 1992;45(4):216–230. doi: 10.1159/000139000. [DOI] [PubMed] [Google Scholar]
  25. de Weille J. R. Modulation of ATP sensitive potassium channels. Cardiovasc Res. 1992 Nov;26(11):1017–1020. doi: 10.1093/cvr/26.11.1017. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES